Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing ImmunityAdviseDx SARS-CoV-2 분석으로 측정된 항-SARS-CoV-2 항체 수준은 이전에 사용 가능한 혈청학적 분석과 일치하지만 살균 면역을 완전히 예측하지는 못합니다Article Published on 2021-08-182022-09-11 Journal: Journal of Clinical Microbiology [Category] MERS, SARS, 변종, 진단, 치료기술, 치료법, [키워드] 95% confidence interval Abbott Abbott Architect anti-SARS-CoV-2 anti-SARS-CoV-2 antibody Anti-spike antibody assay Antigen antigen binding Architect binding Breakthrough infection can not Characteristics clinical sensitivity concordant coronavirus correlates of protection COVID-19 demonstrated described Elecsy ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay Euroimmun examined Factor fishing vessel FIVE Genscript Health care Health care worker healthy humoral Humoral response Immunoglobulin in vitro increasingly individual International international standard international units investigated Level median Neutralizing activity no significant difference outbreak Patient PCR peaked performed positive predicted Protective Protein Quantitative required Roche SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 vaccination seroconverting serologic Serological testing serology seropositive spike IgG Spike protein symptom onset vaccinated individuals vaccination Vaccine vaccine dose variants variants of concern vessel virus neutralization assay WHO widespread wild-type SARS-CoV-2 [DOI] 10.1128/JCM.00989-21 PMC 바로가기 [Article Type] Article
Frequency of Anti-SARS-CoV-2 Antibodies in Various Occupational Sectors in an Industrialized Area of Northern Italy from May to October 2020 †2020년 5월부터 10월까지 이탈리아 북부 산업화 지역의 다양한 직업 분야에서 항 SARS-CoV-2 항체의 빈도 †Article Published on 2021-07-272022-09-12 Journal: International Journal of Environmental Research an [Category] SARS, 진단, [키워드] activity anti-SARS-CoV-2 anti-SARS-CoV-2 IgM Area Arts classification Cluster COVID-19 distribution employment IgG antibodies IgG antibody increased risk Industrial international standard Italy Modena occupational occupational exposure occupational health performed positive proportion SARS-COV-2 infection SARS-CoV2 SARS-CoV2 antibody sector serological test Serological tests serum antibodies serum antibody Standard subject tested work-related risk worker [DOI] 10.3390/ijerph18157948 PMC 바로가기 [Article Type] Article
BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial우간다 신생아의 이종 감염성 질환에 대한 BCG- 유도 비특이적 영향 : 조사관 맹인 무작위 대조 시험Articles Published on 2021-07-012022-09-06 Journal: The Lancet. Infectious Diseases [Category] Communicable Disease, [키워드] 1:1 Abstract addition age all-cause mortality Alter analysed analyses assigned BCG BCG vaccination benefit Birth blind block size block sizes blood sample Blood samples change clinically clinician Comparisons computer-generated Concentration Consent contributed Controlled Controlled trial Cord blood discharged Effect Effects eligible enrolled Entebbe Families finding Follow-up for inclusion funding geometric geometric mean geometric mean ratios gestational age group hazard ratio healthy hepcidin Heterologous hospital IFNγ IL-10 IL-1β IL-6 IL1B IL6 immunological incidence increase in Infant Infants infections Infectious disease inhibited Innate immunity international standard investigated investigators life Luganda material medical intervention modified intention-to-treat mononuclear cell morbidity morbidity and mortality mother Neonatal neonatal period no significant difference non-specific number outcome parent parents participant Peripheral blood Peripheral blood mononuclear cells primary clinical outcome promoter promoter region PROTECT randomisation randomised randomised controlled trial Randomly receive recruited reduce reductions reductions in Registered required saturation Standard Standard dose stratified by sex TNF Transferrin translation Trial Tuberculosis Uganda vaccination Wellcome Trust were excluded with HIV withdrawn [DOI] 10.1016/S1473-3099(20)30653-8 PMC 바로가기 [Article Type] Articles
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative AssaysSARS-CoV-2 항체 수준을 결정하기 위한 스파이크 방지 단백질 분석: 5가지 정량 분석의 일대일 비교Research Article Published on 2021-06-302022-09-12 Journal: Microbiology Spectrum [Category] MERS, SARS, 진단, [키워드] Abbott acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-SARS-CoV-2 antibody Anti-spike antibodies antibody Antibody assays Antibody Response assay standardization assays BAU binding antibody binding antibody unit binding antibody units BNT162b2 calculated comparison coronavirus correlation DiaSorin eliminated evaluated FIVE highlight IgG immunization Immunoglobulin individual International international standard magnitude milliliter neutralization test of BNT162b2 Pfizer/BioNTech quantification Quantitative quantitative antibody assays Quantitative assays quantitative methods Result Roche S1/S2 SARS-CoV-2 sera serology severe acute respiratory syndrome Coronavirus significantly lower single dose Spike protein Standardization suggested surrogate virus neutralization test sVNT tested the antibody response the WHO trimeric spike vaccination Vaccine Vaccine failure viral spike protein virus neutralization test [DOI] 10.1128/Spectrum.00247-21 PMC 바로가기 [Article Type] Research Article
The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis PatientsImmunology Published on 2021-06-162022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] age anti-SARS-CoV-2 antibody appear binding activity BNT162b2 chemiluminescent immunoassay Concentration COVID-19 cut-off value dialysis diarrhea dose event expressed fatigue Hemodialysis hepatitis B high risk IgG IgG antibody immunogenicity immunogenicity data Immunosuppression injection international standard LIAISON local reaction median men Mild moderate mRNA vaccine occurred occurred less Patient patients Pfizer/BioNTech positive response reactive Result Safe Safety SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine Seroconversion seropositive severe COVID-19 significantly higher spike IgG Spike protein systemic systemic side effect the patient the WHO Treatment vaccination Vaccine vaccine dose was determined were assessed women [DOI] 10.3389/fimmu.2021.704773 PMC 바로가기 [Article Type] Immunology
COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care ProfessionalsCOVID-19: 영국 치과 진료 전문가의 혈청 유병률 및 백신 반응Research Reports Published on 2021-06-022022-09-10 Journal: Journal of Dental Research [Category] MERS, SARS, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis anti–SARS-CoV-2 IgG antibodies antibody Antibody Response Antibody responses baseline Care Cohort coronavirus coronavirus disease Coronavirus disease 2019 DCPs dental dentistry Deprivation detectable enzyme-linked immunosorbent enzyme-linked immunosorbent assay estimate exposure to First wave Follow-up future infection greater Guidance health guidance Health Organization Immunological memory individual Infection Infection prevention infection with SARS-CoV-2 initial International international standard leads magnitude natural natural infection occupational exposure occurred pandemic participant Personal protective equipment Pfizer-BioNTech polymerase chain polymerase chain reaction PPE professional public health recruited reduced risk respiratory response retained risk robust SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 spike glycoprotein second wave seroepidemiological studies serological response seropositive Seropositivity Seroprevalence severe acute respiratory syndrome Coronavirus significantly higher single dose spike glycoprotein Support thought United Kingdom vaccination Vaccine was determined West World Health Organization [DOI] 10.1177/00220345211020270 PMC 바로가기 [Article Type] Research Reports
Substance use and substance use disorder, in relation to COVID-19: protocol for a scoping reviewCOVID-19와 관련된 물질 사용 및 물질 사용 장애: 범위 검토를 위한 프로토콜Review Published on 2021-02-032022-08-31 Journal: Systematic Reviews [Category] MERS, 변종, 치료제, [키워드] Abstract affected aggravate alcohol Analysis articles Asian cannabis change CINAHL clinical clinical trial Collection conducted core coronavirus coronavirus disease COVID-19 COVID-19 pandemic creating Data analysis disaster disorder engage English language for inclusion frequencies global health Google Scholar greater Grey literature Health Organization healthcare help index Index Medicus international standard Joanna Briggs Institute literature manual middle mitigate monitoring number Nursing open Open Science Framework opioids original pandemic Population protocol PsycINFO Quantitative registry Research resulting review risk smoke social changes Standard structures substance Substance use Substance use disorder SUD supplementary material thematic analysis variant variants Web of Science WHO World Health Organization [DOI] 10.1186/s13643-021-01605-9 PMC 바로가기 [Article Type] Review
Collaborative study for the calibration of the replacement International Standard for pertussis toxin for use in histamine sensitisation and CHO cell clustering assaysarticle Published on 2019-11-302024-09-01 Journal: Biologicals [Category] 백일해, [키워드] CHO cell clustering assay Histamine sensitisation assay international standard Pertussis toxin [Article Type] article
Evaluation of two WHO First International Standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhiarticle Published on 2019-01-312024-09-01 Journal: Biologicals [Category] 살모넬라증, [키워드] international standard Salmonella Typhi Typhoid conjugate vaccine Vi polysaccharide [Article Type] article
Characterization of the 3rd International Standard for hepatitis B virus surface antigen (HBsAg)Article Published on 2016-09-012023-06-16 Journal: Journal of Clinical Virology [Category] B형 간염, [키워드] HBsAg HBV diagnostics HBV subgenotype immunoassay international standard [DOI] 10.1016/j.jcv.2016.05.009